Free Trial
NYSEARCA:XPH

SPDR S&P Pharmaceuticals ETF (XPH) Price, Holdings, & News

$41.09 +0.65 (+1.61%)
Closing price 04:10 PM Eastern
Extended Trading
$41.13 +0.04 (+0.10%)
As of 04:14 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Key Stats

Today's Range
$40.17
$41.33
50-Day Range
$36.65
$44.71
52-Week Range
$35.22
$48.76
Volume
32,936 shs
Average Volume
47,407 shs
Market Capitalization
$147.92 million
Assets Under Management
$145.78 million
Dividend Yield
1.61%
Net Expense Ratio
0.35%
Aggregate Rating
Moderate Buy

ETF Overview

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Fund invests substantially all, but at least 80%, of its total assets in the securities comprising the Index. In addition, the Fund may invest in equity securities that are not included in the Index, cash and cash equivalents or money market instruments, such as repurchase agreements and money market funds. The Pharmaceuticals Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

SPDR S&P Pharmaceuticals ETF Expenses

TypeXPHHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.35%0.57%0.56%0.51%0.53%
Other Expenses0.00%0.30%0.48%0.56%0.52%
Total Expense0.35%0.70%0.72%0.73%0.71%
Fee Waiver0.00%-0.45%-0.49%-0.66%-0.54%
Net Expense0.35%0.61%0.63%0.58%0.60%
Receive XPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SPDR S&P Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter.

XPH ETF News Headlines

Capture European Growth with This Banking-Focused ETF
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
SPDR® S&P Regional Banking ETF
See More Headlines

XPH ETF - Frequently Asked Questions

SPDR S&P Pharmaceuticals ETF's stock was trading at $42.99 on January 1st, 2025. Since then, XPH stock has decreased by 4.4% and is now trading at $41.09.
View the best growth stocks for 2025 here
.

Top institutional investors of SPDR S&P Pharmaceuticals ETF include First Citizens Bank & Trust Co. (3.30%), Envestnet Portfolio Solutions Inc. (3.15%), U.S. Capital Wealth Advisors LLC (0.41%) and NBC Securities Inc. (0.05%).

Shares of XPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that SPDR S&P Pharmaceuticals ETF investors own include NVIDIA (NVDA), Pfizer (PFE), Adobe (ADBE), Applied Materials (AMAT), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Meta Platforms (META).

Fund Details

Issuer
SSgA
Fund Name
SPDR S&P Pharmaceuticals ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:XPH
Inception Date
6/19/2006
Fund Manager
Michael Feehily, Karl Schneider, Keith Richardson

Fund Focus

Asset Class
Equity
Benchmark
S&P Pharmaceuticals Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
51

Fund Statistics

Assets Under Management
$145.78 million
Average Daily Volume
$70,888.70
Discount/Premium
-0.05%

Administrator, Advisor and Custodian

Administrator
SSgA Funds Management, Inc.
Advisor
SSgA Funds Management, Inc.
Custodian
State Street Bank and Trust Company
Distributor
State Street Global Advisors Funds Distributors, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Citadel

Options

Optionable
Optionable
Options Volume
7
Put Options
2
Call Options
7
Short Interest
1,690,000 shs

Miscellaneous

Beta
0.67
Creation Unit
50,000
Creation Fee
$250.00
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Top 10 XPH Holdings

XPH Sector Exposure

XPH Industry Exposure


This page (NYSEARCA:XPH) was last updated on 4/29/2025 by MarketBeat.com Staff
From Our Partners